Intervention Protocol

Rituximab for rheumatoid arthritis

  1. Maria Angeles Lopez-Olivo1,
  2. Matxalen Amezaga1,
  3. Lynda McGahan2,
  4. Maria E Suarez-Almazor1,*

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 8 OCT 2008

DOI: 10.1002/14651858.CD007356


How to Cite

Lopez-Olivo MA, Amezaga M, McGahan L, Suarez-Almazor ME. Rituximab for rheumatoid arthritis (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007356. DOI: 10.1002/14651858.CD007356.

Author Information

  1. 1

    The University of Texas, M.D. Anderson Cancer Center, General Internal Medicine, Ambulatory Treatment and Emergency Care, Houston, Texas, USA

  2. 2

    Canadian Agency for Drugs and Technologies in Health (CADTH), HTA Directorate, Ottawa, Ontario, Canada

*Maria E Suarez-Almazor, General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 437, Houston, Texas, 77030, USA. msalmazor@mdanderson.org.

Publication History

  1. Publication Status: New
  2. Published Online: 8 OCT 2008

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the efficacy and safety of rituximab for the treatment of RA.